Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial

  1. Chi, K.N.
  2. Protheroe, A.
  3. Rodríguez-Antolín, A.
  4. Facchini, G.
  5. Suttman, H.
  6. Matsubara, N.
  7. Ye, Z.
  8. Keam, B.
  9. Damião, R.
  10. Li, T.
  11. McQuarrie, K.
  12. Jia, B.
  13. De Porre, P.
  14. Martin, J.
  15. Todd, M.B.
  16. Fizazi, K.
Journal:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Year of publication: 2018

Volume: 19

Issue: 2

Pages: 194-206

Type: Article

DOI: 10.1016/S1470-2045(17)30911-7 GOOGLE SCHOLAR